High Impact of Matching Score On Different HSCT Outcomes After Single and Double Umbilical Cord Blood Transplantation for Hematological Malignancies
Mauricette Michallet(Université Claude Bernard Lyon 1), Yves Bertrand(Université Claude Bernard Lyon 1), Valérie Dubois(Établissement Français du Sang), Sothiny Sar(Hôpital Lyon Sud), Stéphane Morisset(Lyon 1 Université), Valérie Chapelle(Hôpital Lyon Sud), Fiorenza Barraco(Hôpital Lyon Sud), Youcef Chelghoum(Hôpital Edouard Herriot), Olivier Héquet(Hôpital Lyon Sud), Xavier Thomas(Hôpital Lyon Sud), Hélène Labussière‐Wallet(Hospices Civils de Lyon), Mohamad Sobh(Ottawa Hospital), Valérie Mialou(Institut d’Hématologie et d’Oncologie Pédiatrique), Franck E. Nicolini(Hôpital Lyon Sud), Sophie Ducastelle(Hôpital Lyon Sud), Jean‐Paul Bourgeot(Établissement Français du Sang), Marie Y. Detrait(Hôpital Civil de Charleroi)
Cited by 0
Related Papers
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials
|Journal of Clinical Oncology|2003|606
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
|Journal of Clinical Oncology|2009|562
Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial
|Journal of Clinical Oncology|2004|547